Mithridion, Inc. - Breaking new ground in drugs for Alzheimer's disease and schizophrenia

Mithridion Corporate Fact Sheet

Click here to download our corporate fact sheet

About Us
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer’s disease and schizophrenia.

Learn More

Recent News	Events
November 12, 2009 - Mithridion Announces Progress with Drugs for Alzheimer’s Disease and Schizophrenia	Bio 2010 & One on One Partnering May 2 - 6, Chicago, IL, USA
April 7, 2009 - Mithridion Announces Phase I Study Results in Alzheimer’s Disease	C21 Bio Ventures May 25 - 27, Napa, CA, USA
March 13, 2009 - Mithridion to Present at Two U.S. National Venture Conferences	Biotech Showcase 2010 Jan. 12 - 13, San Francisco, CA, USA
January 12, 2009 - Mithridion Raises $2.9M of Series B Funding	BioPartnering Europe Oct. 12 - 14, 2009 \| London, UK